pharmaphorum April 11, 2024
Jonah Comstock

It’s 2024, and in most clinical trials, data is still being moved from the EHR to the EDC manually – with employees reading data from one screen and typing it onto another. How did we get here? And how do we get past it?

On today’s pharmaphorum podcast, host Jonah Comstock speaks with Iddo Peleg, CEO of Yonalink, about these very questions.

They discuss the difficulty of innovating in an extremely risk-averse industry like pharma, the downsides of manual data capture, and some of the difficulties involved in automating...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Clinical Trials, Conferences / Podcast, EMR / EHR, Health IT, Technology, Trends
Medtronic, Tempus testing AI to find potential TAVR patients
Legal and ethical challenges in AI-driven clinical trials
Biohaven muscle drug misses goal of SMA study, but advances in obesity
Patient Dies in Gene Therapy Trial, But FDA Permits Neurogene to Proceed With Low Dose
Will Walgreens’ store closures disrupt its clinical trial aims?

Share This Article